Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of antifungals on the intestinal microbiome
2023-503710-69-00Phase 4Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fluconazole (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Gut bacteriome and mycobiome composition and diversity at day 14. Planned start Jul 2023; status: authorised.
02
Drugs
fluconazole
Beyond the preview
Go deeper on 2023-503710-69-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503710-69-00.